Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious diseases, especially hospital-acquired infections. Its commercially available tests are clostridium difficile (C. diff) and Group B Strep. Its system includes an analyzer and a diagnostic cartridge. Each analyzer contains a module into, which individual test cartridges are placed. Its other diagnostic assays in the late stages of product development include a pre-surgical nasal screen for Staphylococcus aureus (SA), food borne pathogen panel, panel for candida blood infections, test for pertussis and a test for Chlamydia tracomatis (CT)/Neisseria gonorrhea (NG). The Company also has a pipeline of assays in an early stage of development, including respiratory testing and sepsis (blood infection) panels. It markets a platform of molecular testing in small to medium sized hospitals.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Equipment, Supplies & Distribution
- Sub-Industry: N/A
- Symbol: NASDAQ:GBSN
- CUSIP: N/A
- Web: gbscience.com/
Average Prices:- 50 Day Moving Avg: $0.08
- 200 Day Moving Avg: $1.13
- 52 Week Range: $0.03 - $2,280,000.00
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 0.00
- P/E Growth: 0.0000
Sales & Book Value:- Annual Revenue: $3.15 million
- Price / Sales: 0.04
- Book Value: ($39.11) per share
- Price / Book: 0.00
Profitability:- EBIDTA: ($30,800,000.00)
- Net Margins: 2,588.36%
- Return on Assets: 168.06%
Misc:- Average Volume: 353,475 shs.
- Beta: 5.09
- Short Ratio: 0.46
Frequently Asked Questions for Great Basin Scientific (NASDAQ:GBSN)
What is Great Basin Scientific's stock symbol?
Great Basin Scientific trades on the NASDAQ under the ticker symbol "GBSN."
When did Great Basin Scientific's stock split? How did Great Basin Scientific's stock split work?
Shares of Great Basin Scientific reverse split on Friday, September 16th 2016. The 1-80 reverse split was announced on Wednesday, September 14th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 15th 2016. An investor that had 100 shares of Great Basin Scientific stock prior to the reverse split would have 1 shares after the split.
How were Great Basin Scientific's earnings last quarter?
Who are some of Great Basin Scientific's key competitors?
Some companies that are related to Great Basin Scientific include Baxter International (BAX), C.R. Bard (BCR), Zimmer Biomet Holdings (ZBH), Align Technology (ALGN), DENTSPLY SIRONA (XRAY), Steris Plc (STE), West Pharmaceutical Services (WST), Bio-Rad Laboratories (BIO), DexCom (DXCM), Hill-Rom Holdings (HRC), VWR Corporation (VWR), Integra LifeSciences Holdings Corporation (IART), ICU Medical (ICUI), LivaNova PLC (LIVN), NuVasive (NUVA), Neogen Corporation (NEOG), Nevro Corp. (NVRO) and Haemonetics Corporation (HAE).
Who are Great Basin Scientific's key executives?
Great Basin Scientific's management team includes the folowing people:
- David Spafford, Executive Chairman of the Board
- Jeffrey A. Rona, Chief Financial Officer
- Robert Jenison, Senior Vice President - Research, Chief Technology Officer
- Ryan Ashton, President, Chief Executive Officer, Director
- Kirk K. Calhoun, Independent Director
- Sam Chawla, Independent Director
- Ronald K. Labrum, Independent Director
How do I buy Great Basin Scientific stock?
Shares of Great Basin Scientific can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Great Basin Scientific's stock price today?
One share of Great Basin Scientific stock can currently be purchased for approximately $0.06.
MarketBeat Community Rating for Great Basin Scientific (NASDAQ GBSN)MarketBeat's community ratings are surveys of what our community members think about Great Basin Scientific and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Great Basin Scientific (NASDAQ:GBSN) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for Great Basin Scientific (NASDAQ:GBSN)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Great Basin Scientific (NASDAQ:GBSN)Earnings History by Quarter for Great Basin Scientific (NASDAQ GBSN)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 3/22/2017 | Q4 2016 | | ($18.25) | | | View | N/A |  |
(Data available from 1/1/2011 forward)
Earnings Estimates for Great Basin Scientific (NASDAQ:GBSN)Current Year EPS Consensus Estimate: $-192.6000 EPS
Next Year EPS Consensus Estimate: $-228.6000 EPS
Dividend History for Great Basin Scientific (NASDAQ:GBSN)
No dividend announcements for this company have been tracked by MarketBeat.com
Headline Trends for Great Basin Scientific (NASDAQ:GBSN)
Latest Headlines for Great Basin Scientific (NASDAQ:GBSN)
| Source: |
|
| Date | Headline |
|---|
 | Great Basin Scientific (GBSN) vs. Ocular Therapeutix (OCUL) Head to Head Analysis
www.americanbankingnews.com - September 14 at 8:20 AM |
| Halyard Health (HYH) & Great Basin Scientific (GBSN) Critical Contrast
www.americanbankingnews.com - August 22 at 8:26 PM |
 | SeeThruEquity Issues Update on Great Basin Scientific (GBSN) on FDA Clearance - Baystreet.ca
www.baystreet.ca - July 19 at 7:36 PM |
 | SeeThruEquity Issues Update on Great Basin Scientific (GBSN) on FDA Clearance
finance.yahoo.com - July 18 at 8:27 PM |
 | Great Basin Scientific Receives FDA 510(k) Clearance for Stool Bacterial Pathogens Panel - GlobeNewswire (press release)
globenewswire.com - July 14 at 1:24 AM |
 | FDA clears Great Basin's stool bacterial pathogens panel
seekingalpha.com - July 13 at 8:22 PM |
| Great Basin Scientific Receives FDA 510(k) Clearance for Stool Bacterial Pathogens Panel
finance.yahoo.com - July 13 at 8:22 PM |
| SeeThruEquity Issues Update on Great Basin Scientific (GBSN)
finance.yahoo.com - July 5 at 7:37 PM |
| Great Basin Scientific Provides Business Update - GlobeNewswire (press release)
globenewswire.com - June 26 at 11:57 PM |
| Great Basin Scientific Provides Business Update
finance.yahoo.com - June 26 at 6:56 PM |
| Great Basin Scientific Closes $2.7 Million Offering of Units - GlobeNewswire (press release)
globenewswire.com - June 22 at 9:33 AM |
| Great Basin Scientific Closes $2.7 Million Offering of Units
finance.yahoo.com - June 22 at 9:33 AM |
| Great Basin Scientific Prices $2.7 Million Registered Offering of Units - GlobeNewswire (press release)
globenewswire.com - June 20 at 11:11 PM |
| Great Basin Scientific Prices $2.7 Million Registered Offering of Units
finance.yahoo.com - June 20 at 6:07 PM |
| Great Basin Scientific, Inc. :GBSN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017
finance.yahoo.com - June 2 at 6:42 PM |
| Data to be Presented at ASM Microbe 2017 Demonstrates the Efficacy of Great Basin's Stool Bacterial Pathogens Panel - GlobeNewswire (press release)
globenewswire.com - June 2 at 4:07 AM |
| Data to be Presented at ASM Microbe 2017 Demonstrates the Efficacy of Great Basin’s Stool Bacterial Pathogens Panel
finance.yahoo.com - June 1 at 6:06 PM |
| Great Basin Scientific Issued Second U.S. Patent for PCR Amplification Suppressor - GlobeNewswire (press release)
globenewswire.com - May 26 at 12:43 AM |
| Great Basin Scientific Reports First Quarter 2017 Results
finance.yahoo.com - May 22 at 11:20 AM |
| Great Basin Scientific Obtains Release of $1.36 Million of Restricted Cash from Series B Convertible Notes - GlobeNewswire (press release)
globenewswire.com - May 16 at 5:19 PM |
| Great Basin Scientific Announces Commercial Launch of Bordetella Direct Test - GlobeNewswire (press release)
globenewswire.com - May 16 at 5:19 PM |
| Great Basin Scientific Announces Commercial Launch of Bordetella Direct Test
finance.yahoo.com - May 16 at 11:37 AM |
| Great Basin Scientific Obtains Release of $1.36 Million of Restricted Cash from Series B Convertible Notes
finance.yahoo.com - May 15 at 11:22 AM |
| Great Basin Scientific, Inc. :GBSN-US: Earnings Analysis: Q4, 2016 By the Numbers : May 8, 2017
finance.yahoo.com - May 8 at 5:09 PM |
| Great Basin Scientific Stock Symbol Reverts to GBSN - GlobeNewswire (press release)
www.globenewswire.com - May 5 at 5:34 PM |
| Great Basin Scientific (GBSN) Earning Somewhat Favorable Media Coverage, AlphaOne Reports
www.americanbankingnews.com - April 25 at 8:36 PM |
| Great Basin Scientific (GBSN) Receives Daily Media Impact Score of 0.27
www.americanbankingnews.com - April 18 at 4:38 PM |
| Great Basin Scientific (GBSN) Receives Daily Coverage Optimism Score of 0.33
www.americanbankingnews.com - April 13 at 11:40 AM |
| Great Basin's Stool Bacterial Pathogens Panel CE Mark'd
seekingalpha.com - April 12 at 9:47 AM |
| Great Basin Scientific Receives CE Marking for Stool Bacterial Pathogens Panel
finance.yahoo.com - April 12 at 9:47 AM |
| Great Basin Scientific Announces Restructuring of Convertible Securities
finance.yahoo.com - April 10 at 11:26 AM |
| Study Published in PLOS ONE Demonstrates Effectiveness of Great ... - GlobeNewswire (press release)
globenewswire.com - April 8 at 9:37 AM |
| Great Basin to reverse split shares 1:2,000 on Monday
seekingalpha.com - April 7 at 5:17 PM |
| Great Basin Scientific Announces Date of Effectiveness of Reverse Stock Split
finance.yahoo.com - April 7 at 5:17 PM |
| Study Published in PLOS ONE Demonstrates Effectiveness of Great Basin Scientific’s Patented Amplification Suppressor Technology
finance.yahoo.com - April 7 at 9:57 AM |
| Great Basin What's Next in the Pipeline Following FDA Clearance for Bordetella Direct Test
finance.yahoo.com - April 7 at 9:57 AM |
| Great Basin Scientific Receives FDA 510(k) Clearance for Bordetella Direct Test
finance.yahoo.com - April 3 at 5:36 PM |
| GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
biz.yahoo.com - March 22 at 5:32 PM |
| Great Basin Scientific Reports Fourth Quarter and Full Year 2016 Results
finance.yahoo.com - March 22 at 5:32 PM |
| GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Regulation FD D
biz.yahoo.com - March 10 at 11:04 AM |
| Great Basin Scientific Receives Stockholder Approval for Reverse ... - GlobeNewswire (press release)
globenewswire.com - March 9 at 10:50 PM |
| Great Basin Scientific Receives Stockholder Approval for Reverse Stock Split and Authorized Share Increase During Special Meeting
finance.yahoo.com - March 9 at 10:50 PM |
| GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equ
biz.yahoo.com - March 3 at 5:24 PM |
| Great Basin Scientific’s Suzette Chance Named a 2017 Woman Worth Watching in STEM by Profiles in Diversity Journal
finance.yahoo.com - March 2 at 10:44 AM |
| Great Basin Scientific's Staph ID/R Blood Culture Panel Clinical ... - GlobeNewswire (press release)
globenewswire.com - February 17 at 8:48 AM |
| GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to
biz.yahoo.com - February 17 at 8:48 AM |
| GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Material Modification
biz.yahoo.com - February 17 at 8:48 AM |
| Great Basin Scientific’s Staph ID/R Blood Culture Panel Clinical Evaluation and Rapid Identification Analysis Published in Journal of Clinical Microbiology
finance.yahoo.com - February 16 at 5:18 PM |
| GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and
biz.yahoo.com - February 14 at 6:28 PM |
| Great Basin Scientific Announces Filing of Registration Statement on Form S-1
finance.yahoo.com - February 14 at 6:28 PM |
Great Basin Scientific (GBSN) Chart for Saturday, September, 23, 2017
